Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 28 | 30 | +2 |
| Shares | 6.25M | 6.24M | −10.4K (−0.2%) |
| Value | $14.4M | $14.7M | +$348.4K (+2.4%) |
New holders (7)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 30,810 | $72.7K | 0.00% |
| Charles Schwab Investment Management Inc | 14,987 | $35.4K | 0.00% |
| Veritable, L.P. | 13,029 | $30.7K | 0.00% |
| Millennium Management LLC | 12,605 | $30.0K | 0.00% |
| Ameritas Advisory Services, LLC | 1,000 | $2.27K | 0.00% |
| Group One Trading, L.P. | 600 | $1.42K | 0.00% |
| Simplex Trading, LLC | 69 | $0 | 0.00% |
Sold out (5)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Eversept Partners, LP | 67,743 | $154.5K |
| Rockefeller Capital Management L.P. | 1,666 | $3.00K |
| Bank of America Corp | 14 | $32 |
| Morgan Stanley | 1 | $2 |
| IFP Advisors, Inc | 1 | – |